Literature DB >> 14620748

Comparison of the efficacy and longevity of nonpenetrating glaucoma surgery with and without a new, nonabsorbable hydrophilic implant.

Elie Dahan1, Emilie Ravinet, Guy J Ben-Simon, Andre Mermoud.   

Abstract

BACKGROUND AND
OBJECTIVE: To compare the efficacy and longevity of nonpenetrating glaucoma surgery with and without the use of a nonabsorbable hydrophilic implant at the Oxford Eye Centre, Johannesburg, South Africa, and the Glaucoma Unit, Jules Gonin Ophthalmic Hospital, Lausanne, Switzerland. PATIENTS AND METHODS: In a nonrandomized, prospective study between March 1997 and December 2001, 48 eyes of 32 patients aged 18 to 86 years with primary open-angle glaucoma underwent nonpenetrating glaucoma surgery; 25 eyes with the implant and 23 eyes without it. Intraocular pressure (IOP) was recorded preoperatively and postoperatively at 1, 7, and 14 days, at 1, 3, and 6 months, and thereafter every 6 months.
RESULTS: The mean preoperative IOP was 27.5 +/- 11.8 mm Hg (range, 20 to 64 mm Hg) in the implant group and 24.8 +/- 7.1 mm Hg (range, 16 to 38 mm Hg) in the control group. During the first 18 months of follow-up, both groups showed identical IOP progression and the mean IOP remained less than 14 mm Hg. After 2 years of follow-up, the IOP started to rise in the control group but remained stable in the implant group. After 30 months, the mean IOP was 12.4 +/- 2 mm Hg and the IOP decrease in percentage was 62% +/- 6% in the implant group (n = 13) versus 16.1 +/- 3 mm Hg and 34% +/- 13% in the control group (n = 15) (mean IOP, P = .0022; mean IOP decrease in percentage, P = .01).
CONCLUSIONS: During the first 18 months, there was no difference in the outcomes between the two groups. After 2 years of follow-up, the mean IOP was lower and the IOP decrease in percentage was greater in the implant group compared with the control group.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14620748

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  6 in total

1.  Migration of reticulated hyaluronic acid implant [SK-GEL] following deep sclerectomy.

Authors:  Saleh A Al Obeidan
Journal:  Int Ophthalmol       Date:  2009-10-22       Impact factor: 2.031

2.  Intrascleral outflow after deep sclerectomy with absorbable and non-absorbable implants in the rabbit eye.

Authors:  Jakub J Kałużny; Dariusz Grzanka; Halina Wiśniewska; Alicja Niewińska; Bartłomiej J Kałużny; Alina Grzanka
Journal:  Med Sci Monit       Date:  2012-10

3.  Clinical options for the reduction of elevated intraocular pressure.

Authors:  Laura Crawley; Sohaib M Zamir; Maria F Cordeiro; Li Guo
Journal:  Ophthalmol Eye Dis       Date:  2012-04-30

4.  Phacoemulsification combined with deep sclerectomy augmented with mitomycin and amniotic membrane implantation in chronic primary open angle glaucoma with cataract.

Authors:  Hazem Helmy
Journal:  Electron Physician       Date:  2016-04-25

5.  Self-engineered Acry C plants in nonpenetrating glaucoma surgery.

Authors:  Sudhir Pendke; Sanchit Bhalgat
Journal:  Oman J Ophthalmol       Date:  2018 Jan-Apr

6.  SKGEL® implant versus T-Flux® implant in the contralateral eye in deep sclerectomy with phacoemulsification: long-term follow-up.

Authors:  Frank Schreyger; Gabor Scharioth; Holger Baatz
Journal:  Open Ophthalmol J       Date:  2008-03-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.